Tue, 26 Aug 2008 14:42:59 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en 2007 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/Immunology/immunology_art_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Immunology no PeerView Press In this CME/CE activity, experts in the treatment of primary immune deficiency (PID) present recent data on intravenous and subcutaneous immunoglobulin therapies used in the treatment of this condition. The efficacy and safety of these treatments are discussed. Administration issues for both the nurse and the physician are reviewed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the treatment of primary immune deficiency (PID) present recent data on intravenous and subcutaneous immunoglobulin therapies used in the treatment of this condition. The efficacy and safety of these treatments are discussed. Administration issues for both the nurse and the physician are reviewed. http://podcast.peerviewpress.com/immunology/PA03653FCr264.mp3 http://podcast.peerviewpress.com/immunology/PA03653FCr264.mp3 Wed, 10 Jan 2007 16:05:28 -0500 Science & Medicine no 00:32:44 primary immune deficiency,PID,intravenous immunoglobulin,subcutaneous immunoglobulin,IVIG,SCIG,agammaglobulinemia,bacteria, infections,SBI,home administration,anaphylaxis,thrombosis,trough levels,health-related quality of life,HRQoL,premedication,infusion PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/immunology/PA03653FCCMECEinfo.pdf http://podcast.peerviewpress.com/immunology/PA03653FCCMECEinfo.pdf Wed, 10 Jan 2007 16:05:23 -0500 Science & Medicine no 00:00:00 primary immune deficiency,PID,intravenous immunoglobulin,subcutaneous immunoglobulin,IVIG,SCIG,agammaglobulinemia,bacteria, infections,SBI,home administration,anaphylaxis,thrombosis,trough levels,health-related quality of life,HRQoL,premedication,infusion